Canadian generic drug manufacturer Apotex is looking to raise C$1.2 billion ($868 million) in an initial public offering in Toronto https://t.co/yfBj7wRFsA
Apotex seeks to raise C$1.2B in Toronto IPO, marking a major test for Canada’s public markets